Project measure / variable:   Wiltshire2   TST_fluox

ID, description, units MPD:38002   TST_fluox   TST duration of immobility   [%]  fluoxetine  
fluoxetine study
Data set, strains Wiltshire2   inbred   30 strains     sex: m     age: 9-10wks
Procedure tail suspension test
Ontology mappings

  •   Or, add this measure to your collection.
       
  •     no folder
  •     put it in new folder  

  STRAIN COMPARISON PLOT
Dimensions Width:   px    Height:   px
Download Plot   
Visualization Options

Wiltshire2 - TST duration of immobility fluoxetine



  MEASURE SUMMARY
Measure Summary Male
Number of strains tested30 strains
Mean of the strain means24.4   %
Median of the strain means22.2   %
SD of the strain means± 15.1
Coefficient of variation (CV)0.617
Min–max range of strain means1.25   –   55.9   %
Mean sample size per strain10.4   mice


  ANOVA, Q-Q NORMALITY ASSESSMENT
ANOVA summary      
FactorDFSum of squaresMean sum of squaresF valuep value (Pr>F)
strain 29 66957.9536 2308.895 20.5077 < 0.0001
Residuals 288 32424.974 112.5867


Q-Q normality assessment based on residuals

  


  STRAIN MEANS (UNADJUSTED)
  
Select table page:
Strain Sex Mean SD N mice SEM CV Min, Max Z score
129S1/SvImJ m 32.0 10.4   12 2.99 0.324 17.7, 49.9 0.5
A/J m 32.1 5.35   13 1.48 0.167 23.1, 40.9 0.51
AKR/J m 47.5 12.3   8 4.34 0.258 24.1, 61.7 1.53
BALB/cJ m 15.7 9.52   19 2.19 0.606 1.83, 32.4 -0.58
BTBR T+ Itpr3tf/J m 2.04 3.55   9 1.18 1.74 -1.49
BUB/BnJ m 27.0 8.72   9 2.91 0.323 15.2, 40.5 0.17
C3H/HeJ m 31.2 12.8   14 3.42 0.41 0.17, 50.3 0.45
C57BL/6J m 28.8 9.75   9 3.25 0.339 9.8, 40.1 0.29
C57BLKS/J m 20.2 13.7   11 4.12 0.678 0.94, 45.3 -0.28
C57BR/cdJ m 9.24 9.57   11 2.88 1.03 -1.01
C58/J m 23.1 5.98   9 1.99 0.259 15.2, 32.0 -0.09
CBA/J m 12.5 8.87   14 2.37 0.711 3.06, 32.6 -0.79
CE/J m 21.4 9.55   12 2.76 0.447 0.9, 32.9 -0.2
DBA/2J m 5.29 4.17   10 1.32 0.788 -1.27
FVB/NJ m 19.6 9.04   8 3.2 0.463 5.4, 31.3 -0.32
I/LnJ m 21.4 13.5   7 5.12 0.632 6.3, 42.4 -0.2
LG/J m 1.25 1.18   9 0.394 0.945 0.06, 4.17 -1.54
LP/J m 49.4 19.5   13 5.42 0.396 11.6, 83.7 1.65
MA/MyJ m 9.42 8.78   9 2.93 0.931 0.3, 25.5 -1.0
MRL/MpJ m 4.06 4.23   8 1.49 1.04 -1.35
NOD/ShiLtJ m 39.2 6.84   11 2.06 0.174 29.2, 51.3 0.98
NOR/LtJ m 23.5 16.6   10 5.25 0.706 2.06, 51.9 -0.06
NZB/BlNJ m 55.9 7.42   10 2.35 0.133 47.5, 70.9 2.09
NZW/LacJ m 45.0 14.3   9 4.76 0.318 8.2, 54.8 1.36
P/J m 11.3 9.75   12 2.81 0.862 2.7, 32.1 -0.87
PL/J m 38.2 9.7   10 3.07 0.254 20.8, 51.8 0.91
RIIIS/J m 9.1 10.6   12 3.05 1.16 0.06, 36.8 -1.02
SJL/J m 40.5 14.2   11 4.29 0.351 20.7, 63.0 1.06
SM/J m 38.1 9.78   7 3.7 0.257 27.7, 50.6 0.91
SWR/J m 19.3 11.9   12 3.44 0.615 1.4, 40.6 -0.34


  LEAST SQUARES MEANS (MODEL-ADJUSTED)
Strain Sex Mean SEM UpperCL LowerCL
129S1/SvImJ m 32.0333 3.063 38.0621 26.0045
A/J m 32.0615 2.9429 37.8538 26.2693
AKR/J m 47.55 3.7514 54.9337 40.1663
BALB/cJ m 15.7168 2.4343 20.508 10.9256
BTBR T+ Itpr3tf/J m 2.0389 3.5369 9.0003 0.0
BUB/BnJ m 27.0111 3.5369 33.9726 20.0497
C3H/HeJ m 31.1836 2.8358 36.7651 25.602
C57BL/6J m 28.7556 3.5369 35.717 21.7941
C57BLKS/J m 20.18 3.1992 26.4769 13.8831
C57BR/cdJ m 9.2427 3.1992 15.5396 2.9459
C58/J m 23.1222 3.5369 30.0837 16.1608
CBA/J m 12.4793 2.8358 18.0609 6.8977
CE/J m 21.3583 3.063 27.3871 15.3295
DBA/2J m 5.294 3.3554 11.8982 0.0
FVB/NJ m 19.55 3.7514 26.9337 12.1663
I/LnJ m 21.4429 4.0105 29.3364 13.5493
LG/J m 1.2489 3.5369 8.2103 0.0
LP/J m 49.3615 2.9429 55.1538 43.5693
MA/MyJ m 9.4222 3.5369 16.3837 2.4608
MRL/MpJ m 4.065 3.7514 11.4487 0.0
NOD/ShiLtJ m 39.2182 3.1992 45.515 32.9213
NOR/LtJ m 23.488 3.3554 30.0922 16.8838
NZB/BlNJ m 55.93 3.3554 62.5342 49.3258
NZW/LacJ m 44.9778 3.5369 51.9392 38.0163
P/J m 11.3083 3.063 17.3371 5.2795
PL/J m 38.22 3.3554 44.8242 31.6158
RIIIS/J m 9.1025 3.063 15.1313 3.0737
SJL/J m 40.4727 3.1992 46.7696 34.1759
SM/J m 38.1 4.0105 45.9935 30.2065
SWR/J m 19.3467 3.063 25.3755 13.3179




  GWAS USING LINEAR MIXED MODELS